Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
EUR 46,13
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 1.35.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 63,61
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Lucky's Textbooks, Dallas, TX, U.S.A.
EUR 62,42
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: HPB-Red, Dallas, TX, U.S.A.
EUR 64,98
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Da: Books Puddle, New York, NY, U.S.A.
EUR 65,49
Convertire valutaQuantità: 4 disponibili
Aggiungi al carrelloCondizione: New. 1 edition NO-PA16APR2015-KAP.
Da: California Books, Miami, FL, U.S.A.
EUR 70,10
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 71,24
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Majestic Books, Hounslow, Regno Unito
EUR 65,91
Convertire valutaQuantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 65,90
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 70,20
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 85,88
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloCondizione: New.
Editore: Chapman and Hall/CRC 2021-03-31, 2021
ISBN 10: 0367727072 ISBN 13: 9780367727079
Lingua: Inglese
Da: Chiron Media, Wallingford, Regno Unito
EUR 69,38
Convertire valutaQuantità: 10 disponibili
Aggiungi al carrelloPaperback. Condizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 87,37
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 78,22
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 78,20
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 78,18
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Editore: Chapman and Hall/CRC 2019-06-28, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Lingua: Inglese
Da: Chiron Media, Wallingford, Regno Unito
EUR 77,85
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 88,23
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Revaluation Books, Exeter, Regno Unito
EUR 94,12
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 442 pages. 9.21x6.14x1.10 inches. In Stock.
Editore: Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Lingua: Inglese
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 122,28
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
EUR 84,89
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
Da: Lucky's Textbooks, Dallas, TX, U.S.A.
EUR 140,46
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: California Books, Miami, FL, U.S.A.
EUR 157,95
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Majestic Books, Hounslow, Regno Unito
EUR 151,22
Convertire valutaQuantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: Books Puddle, New York, NY, U.S.A.
EUR 163,60
Convertire valutaQuantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 169,46
Convertire valutaQuantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Editore: Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Lingua: Inglese
Da: Rarewaves.com UK, London, Regno Unito
EUR 113,33
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 168,23
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: New. New. Ships from Multiple Locations. book.
Da: Revaluation Books, Exeter, Regno Unito
EUR 210,12
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 415 pages. 9.50x6.50x1.25 inches. In Stock.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 68,78
Convertire valutaQuantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.